ISSN: 1939-067X

Journal of Experimental Stroke & Translational Medicine

Atherogenic Dyslipidemia High Impact Factor Journals

 Atherogenic dyslipidaemia is one among the metabolic abnormalities that outline the metabolic syndrome, the cluster of vessel risk factors often related to intra-abdominal (or visceral) fleshiness. This section outlines the parts of the dyslipidaemia that characterizes intra-abdominal fleshiness and therefore the metabolic syndrome, in addition as their causes and impact on upset (CVD) risk. a quick review of the intravascular lipoid transport system can facilitate place the dyslipidemia of intra-abdominal fleshiness in correct context. The major lipids concerned in dyslipidemia area unit cholesterin and triglycerides. These lipids area unit insoluble in blood (like oil in water) and should be prepacked into molecule lipid-protein complexes known as lipoproteins for export to different organs (Figure 1). Lipoproteins area unit classified in keeping with their lipoid and macromolecule composition. the foremost conjugated protein categories area unit as follows: chylomicrons, very-low-density lipoproteins (VLDL), remnants (or intermediate-density lipoproteins, IDL), low-density lipoproteins (LDL), and high-density lipoproteins (HDL). Chylomicrons and very low density lipoprotein area unit the most transporters of dietary and endogenous triglycerides severally, whereas LDL and high-density lipoprotein primarily carry cholesterin between the liver and extrahepatic tissues. Severe or untreated dyslipidemia can lead to other conditions, including coronary artery disease (CAD) and peripheral artery disease (PAD). Both CAD and PAD can cause serious health complications, including heart attacks and strokes

High Impact List of Articles

Relevant Topics in Clinical